Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.54 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Kenvue Just IPO'd, but Is the Stock a Buy?
The Johnson & Johnson spinoff is worth considering, but it's not a must-buy. 
Via The Motley Fool
Tesla, Apple, Microsoft Stakes Slashed By New York State Retirement Fund In Q1: Here's What It Bought
 
Via Benzinga
Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
7 High-Quality Dow Stocks to Buy on the Dip
These seven Dow stocks each trade at attractive valuations, and have the potential to produce steady long-term returns. 
Via InvestorPlace
3 Reliable Dividend Stocks That Fit in Any Investor’s Portfolio
There are some reliable dividend stocks that everyone can and should consider owning. Here are three of them that fit the bill. 
Via InvestorPlace
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Benzinga 
Via Benzinga
2 Dividend Stocks to Double Up On Right Now
These dividend stocks look attractive right now. 
Via The Motley Fool
Johnson & Johnson Sets Aside $400M To End US State Consumer Protection Claims
As a part of the $8.9 billion effort to settle claims related to talc products, Johnson & Johnson (NYSE: 
Via Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
You don't need a mountain of cash to build wealth on Wall Street. 
Via The Motley Fool
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
These stocks provide good value and can be excellent sources of recurring income. 
Via The Motley Fool
Don’t Panic. 3 Defensive Stocks to Diversify Into ASAP
Here are three defensive stocks all long-term investors worried about the macro environment may want to consider right now. 
Via InvestorPlace
These 6 Stocks Are Relentless Dividend Growers
Today I tell you about 6 dividend growth stocks that just increased their dividends. Check out the video for full details. 
Via Talk Markets
Kenvue Has Gone Public: Should You Buy the Stock?
Its business could be resistant to the effects of inflation. 
Via The Motley Fool
Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?
Both stocks have built-in economic diversity and are solid long-term investments. 
Via The Motley Fool
Elliot Wave Technical Analysis: S&P 500 - Sunday, May 14
Via Talk Markets
Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks
Here are seven must-have dividend stocks for long-term investing that you can consider for your dividend stock portfolio. 
Via InvestorPlace
3 Bargain Dividend Stocks to Boost Your Passive Income
Here are just a few of the top bargain dividend stocks to boost your passive income as we get deeper into 2023. 
Via InvestorPlace
2 No-Brainer Healthcare Stocks to Buy Right Now
Boring businesses can make for beautiful lifelong holdings -- these two stocks show us why. 
Via The Motley Fool
Where to Invest $10,000 in a Bear Market
Cautious and aggressive investors both might find opportunities in a bear market. 
Via The Motley Fool
Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment
Protagonist Therapeutics (NASDAQ: PTGX) reported data from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE: JNJ), on Phase 1 and preclinical studies of  
Via Benzinga
How Apple Pleased Investors
We've got a lot of ground to cover as company earnings reports continue to flood in. 
Via The Motley Fool
7 Overvalued Stocks to Sell for May 2023
It's easy to fall into the trap of getting overvalued stocks. What may have been a great buy a year ago could be overvalued today. 
Via InvestorPlace
Tesla, IONQ, Nano-X, Peloton, Hepion: Why These 5 Stocks Are Drawing Investors' Attention Today
 
Via Benzinga
The Surprising Reason Nanox Stock Jumped Again Today
This $400 billion dollar company just increased its investment in Nanox by 62%. 
Via The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These stocks may help your portfolio thrive over time. 
Via The Motley Fool
2 Warren Buffett Stocks to Buy Hand Over Fist in May
These two Berkshire Hathaway holdings are solid picks in May. 
Via The Motley Fool
Is ChatGPT A Better Financial Advisor? We're Going To Find Out
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
3 Dividend Stocks Set to Hike Payouts in 2023
Here are three dividend stocks with rising dividends in 2023. Each stock is also a good buy-and-hold candidate in a volatile market. 
Via InvestorPlace
Artificial Intelligence Engine Predicts PACW Stock to Gain 11% by June 7
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.